@BR_CMR

Associate Professor of Cardiovascular Medicine, Wellcome Career Development Fellow, Specialty Associate Editor for @CircAHA, University of Oxford

 Oxford, UK
Joined March 2018
  • Tweets1K
  • Following481
  • Followers982
36Media
Betty Raman retweeted
JACC Journals@JACCJournalsOct 22
💊 Can SGLT2 inhibitors improve outcomes in transthyretin cardiac #Amyloidosis? A #JACCAdvances meta-analysis of 14 observational studies (n=10,852) found #SGLT2i use was associated with 56% lower all-cause mortality & 38% lower HF hospitalization. bit.ly/4sjrhPO
4
43
1
115
6,396
Large V-waves are common in HF patients, but their significance has been unclear. Here’s why it matters: they augment RV afterload independent of the lung vessels, with implications for how we assess pulmonary vascular disease. #HFSA2026 @CircAHA
Circulation@CircAHAOct 11
Large V-waves are encountered often in HF patients, but unclear clinical significance. Borlaug et al. dig deeper. In ≈1100 HFpEF patients, prom. V-waves tracked w/ L-atrial myopathy, greater pulmonary hypertension,... #HFSA2026 ahajrnls.org/4s2fxRJ @yreddyhf @TChaikijurajai
5
15
799
This week, @CircAHA goes into space. @AppaduraiVinesh et al. followed 13 astronauts with echocardiography before and during spaceflight, a median of 164 days. Early reductions in LV chamber size and stroke volume occurred within 14 days, then returned toward normal with longer exposure. Good news for future long-term space expeditions: 6 months of microgravity did not appear to cause sustained abnormalities in LV cardiac structure or function. ahajournals.org/doi/full/10.… @AHAScience | #Cardiology #Spaceflight
2
10
2
34
1,854
Clinical Problem Solving: The management of ventricular tachycardia (VT) is rarely straightforward, and clinicians must consider all eventualities. In this week's @CircAHA Clinical Problem Solving section, Nielson et al. (@WilcoxHeart, @NishantVermaMD) discuss a real patient case with challenges and unexpected findings at every turn: a primer on the causes of VT, its treatment, and a few new lessons for us all. Full article: ahajournals.org/doi/full/10.… @AHAScience | #VentricularTachycardia #Cardiology
Circulation "Clinical Problem Solving" graphic with the article title "When VT Storm, PET Positivity, and a Negative Endomyocardial Biopsy Collide" and the excerpt "The management of ventricular tachycardia (VT) is rarely straightforward..." On the right, an eight-step flowchart with small illustrations shows the approach to managing refractory VT storm, from stabilizing the patient through long-term management. The footer reads "@CircAHA #Cardiology | Vol 154, No 14 | Nielson et al."

ALT Circulation "Clinical Problem Solving" graphic with the article title "When VT Storm, PET Positivity, and a Negative Endomyocardial Biopsy Collide" and the excerpt "The management of ventricular tachycardia (VT) is rarely straightforward..." On the right, an eight-step flowchart with small illustrations shows the approach to managing refractory VT storm, from stabilizing the patient through long-term management. The footer reads "@CircAHA #Cardiology | Vol 154, No 14 | Nielson et al."

8
16
941
Betty Raman retweeted
Circulation@CircAHASep 25
This week on Circulation on the Run: Author @GarimaVSharmaMD discusses her Clinicians' Corner on Postpartum Monitoring for Hypertensive Disorders of Pregnancy Through Community-Clinical Linkages. ahajrnls.org/4hyavaO
1
5
10
2,908
Clinician Lighthouse: Patients often present with unexpected findings — including a newly discovered bundle branch block. New LBBB and RBBB interpretation has evolved, and it matters for every clinician, not just EPs. This week, Dr. Jeremy Treger et al. walk through a stepwise approach to diagnosis. Here's why it matters: in their case, a new LBBB meant an EF of 25%. After conduction, system pacing corrected it, EF normalized to 62%. A new BBB is a clue, not a final answer. Keep your clinical skills sharp at @CircAHA... Full piece: ahajournals.org/doi/full/10.… @AHAScience | #Circulation #Cardiology
Square Circulation graphic. Top left: AHA torch-and-heart mark beside "Circulation" in red. A red-and-gray double rule spans the width below it. Left column: "Clinician Lighthouse" as the series title, "Clinician" in red and "Lighthouse" in black, followed by a short red divider line and the bold black headline "A new bundle branch block is a clue, not a final answer." Below that, a bordered callout with a red heart-pulse icon reads "EF 25% → 62% in four months." Top right: a watercolor illustration of two overlapping circles — one warm orange with a heartbeat line and small figures, one pale blue with a checklist and speech-bubble icon — rising as a thought bubble from a red armchair. A red footer bar across the bottom reads "VOL 154, NO 12 | CIRCULATION" on the left and "Jeremy S. Treger, Karol Čurila, Gaurav A. Upadhyay" in italic on the right.

ALT Square Circulation graphic. Top left: AHA torch-and-heart mark beside "Circulation" in red. A red-and-gray double rule spans the width below it. Left column: "Clinician Lighthouse" as the series title, "Clinician" in red and "Lighthouse" in black, followed by a short red divider line and the bold black headline "A new bundle branch block is a clue, not a final answer." Below that, a bordered callout with a red heart-pulse icon reads "EF 25% → 62% in four months." Top right: a watercolor illustration of two overlapping circles — one warm orange with a heartbeat line and small figures, one pale blue with a checklist and speech-bubble icon — rising as a thought bubble from a red armchair. A red footer bar across the bottom reads "VOL 154, NO 12 | CIRCULATION" on the left and "Jeremy S. Treger, Karol Čurila, Gaurav A. Upadhyay" in italic on the right.

1
6
10
776
Inside the Journal: Cardiovascular disease doesn't respect borders. We're honored to have Dr. Ana Mocumbi join @CircAHA as our new Deputy Editor for Global Cardiovascular Health — her Perspective this week argues that tools like portable battery-powered ultrasound will drive key solutions. Here's why it matters: LMIC countries carry a growing share of global CV deaths but produce under 4% of the research. Ana also joined this week's #CircOnTheRun podcast — walked through her vision in a fantastic conversation, and yes, she speaks seven languages... Podcast 🎧: ahajournals.org/do/10.1161/p… Full piece: ahajournals.org/doi/full/10.… @American_Heart | #Circulation #GlobalHealth
Circulation cover (Volume 154, Number 11, September 15, 2026) on the left, with the "The Future of Global Cardiovascular Health Research at Circulation" Perspective entry (AO Mocumbi, p. 963) circled in orange. Center: a photo of Dr. Ana Mocumbi in a red shawl. Right side: bold red text reading "INSIDE THE JOURNAL: The Future of Global Cardiovascular Health Research at Circulation, WITH: DR. ANA MOCUMBI," a microphone icon with "LISTEN: APPLE & SPOTIFY," an arrow pointing to the Circulation on the Run podcast cover art, and the AHA logo on the cover panel.

ALT Circulation cover (Volume 154, Number 11, September 15, 2026) on the left, with the "The Future of Global Cardiovascular Health Research at Circulation" Perspective entry (AO Mocumbi, p. 963) circled in orange. Center: a photo of Dr. Ana Mocumbi in a red shawl. Right side: bold red text reading "INSIDE THE JOURNAL: The Future of Global Cardiovascular Health Research at Circulation, WITH: DR. ANA MOCUMBI," a microphone icon with "LISTEN: APPLE & SPOTIFY," an arrow pointing to the Circulation on the Run podcast cover art, and the AHA logo on the cover panel.

4
13
460
Advance your expertise in HCM imaging with the #EACVI HCM Masterclass 24-25 September in Lisbon, Portugal. This intensive 1.5-day course is designed for cardiologists establishing an #HCM clinic and those wishing to specialise in hypertrophic cardiomyopathy. Learn from international experts through case-based discussions and multimodality imaging sessions. 👉 Discover more and register: esc365.escardio.org/event/26… #CVImaging #echofirst #CCT #whyCMR @rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @samsrivastava77 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez @Sarah_Moharem @denisamuraru @s_e_petersen @VictoriaDe32503
1
19
40
2,070
Editor's Perspective: The management of acute myocardial infarction is elemental to cardiovascular medicine. This week in @CircAHA, Marco Valgimigli (@vlgmrc) and colleagues lay out a state-of-the-art review spanning STEMI, NSTEMI, and MINOCA management. Here's why it matters: this paper summarizes where we are — and where we still need to go, including AI-supported diagnosis of occlusive MI, new thrombus management devices, and selective anti-inflammatory therapies. Full piece: ahajournals.org/doi/full/10.… @American_Heart | #Circulation #MyocardialInfarction
Split graphic. Left: Circulation logo, with "EDITOR'S PERSPECTIVE: Clinical Management of Myocardial Infarction" and author credit (Landi, Malik, Chieffo, Valgimigli). Right: the review's central wheel diagram, showing acute management (reperfusion, antiplatelet/anticoagulant therapy, revascularization) transitioning to long-term secondary prevention (lipid-lowering therapy, cardiac rehab, lifestyle measures), with STEMI/NSTEMI/MINOCA consideration boxes above and a Future Directions box (AI-supported diagnosis, new thrombus devices, anti-inflammatory therapies) below.

ALT Split graphic. Left: Circulation logo, with "EDITOR'S PERSPECTIVE: Clinical Management of Myocardial Infarction" and author credit (Landi, Malik, Chieffo, Valgimigli). Right: the review's central wheel diagram, showing acute management (reperfusion, antiplatelet/anticoagulant therapy, revascularization) transitioning to long-term secondary prevention (lipid-lowering therapy, cardiac rehab, lifestyle measures), with STEMI/NSTEMI/MINOCA consideration boxes above and a Future Directions box (AI-supported diagnosis, new thrombus devices, anti-inflammatory therapies) below.

9
16
812
Editor's Perspective: Two new papers in @CircAHA this week (@JKassabMD et al., B. Lindman et al.) show how often guideline-recommended echo follow-up for aortic stenosis — moderate and severe — gets missed, even as treatment options keep improving. Why it Matters: Proven treatments are available; the opportunity to use them on time appears to be missed. Direct links to both pieces: ahajournals.org/doi/10.1161/… ahajournals.org/doi/10.1161/… @American_Heart | #Circulation #AorticStenosis
Graphic split into three sections on a white background. Far left: bold red text reading "Editor's Perspective" above a professional headshot of Dr. Bradley Maron. Center: the September 8, 2026 cover of Circulation (Volume 154, Number 10, ISSN 0009-7322), showing the table of contents on the left side and a colorful fluorescent microscopy image (Zhang et al., p. 934) on the right. Two entries in the Original Research and Research Letters sections are circled in orange: "Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry" by BR Lindman ... S Vemulapalli (p. 892), and "Guideline-Recommended Follow-Up for Moderate AS in the US" by J Kassab ... DJ Kumbhani (p. 956). AHA logo. Far right: a large pull-quote in bold red text reading "Here's why it matters: the treatments now exist. What these studies show is that the opportunity to use them on time is still being missed," attributed to -Bradley Maron.

ALT Graphic split into three sections on a white background. Far left: bold red text reading "Editor's Perspective" above a professional headshot of Dr. Bradley Maron. Center: the September 8, 2026 cover of Circulation (Volume 154, Number 10, ISSN 0009-7322), showing the table of contents on the left side and a colorful fluorescent microscopy image (Zhang et al., p. 934) on the right. Two entries in the Original Research and Research Letters sections are circled in orange: "Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry" by BR Lindman ... S Vemulapalli (p. 892), and "Guideline-Recommended Follow-Up for Moderate AS in the US" by J Kassab ... DJ Kumbhani (p. 956). AHA logo. Far right: a large pull-quote in bold red text reading "Here's why it matters: the treatments now exist. What these studies show is that the opportunity to use them on time is still being missed," attributed to -Bradley Maron.

2
4
1
12
1,908
Betty Raman retweeted
Qiang Zhang@QiangZhangAiCmrSep 5
Big data approach at population scale unveiled more, holistic insights about patterns of multi-organ fat distribution and how they contribute to disease risks.
European Society of Cardiology Journals
@ESC_JournalsAug 31
Mapping organ fat distribution and body composition: towards precision profiling of cardiometabolic disease risks ow.ly/U6Na50ZELKE #ESCCongress #EHJ @ehj_ed @s_e_petersen
1
1
3
139
Inside the Journal: Population health in cardiovascular medicine is moving fast. This week's Perspective from @MCarnethon, the new Deputy Editor for Population Health at @CircAHA, makes the case for chasing the "unusual" in cardiovascular disease. Here's why it matters: the uncommon and unexplained — an understudied population, a signal a wearable is already capturing — is where the next real insight is hiding. A good note to end #ESCCongress week on. Read her full Perspective: ahajournals.org/doi/full/10.… @American_Heart | #Circulation #PopulationHealth
Split graphic. Left panel: the September 1, 2026 cover of Circulation (Volume 154, Number 9), with the Commentary/Perspectives entry "Searching for the Uncommon: The Future of Population Science in Cardiovascular Disease" by M.R. Carnethon (p. 787) circled in orange. Right panel, on a light gray background: bold red text reading "INSIDE THE JOURNAL:" above "MERCEDES CARNETHON, PHD" in gray, with "Deputy Editor, Population Health" below in italic gray. A circular headshot of Dr. Carnethon — smiling, dark hair, wearing a blue top — sits in the lower right, framed in red. AHA logo in the lower left of the cover panel.

ALT Split graphic. Left panel: the September 1, 2026 cover of Circulation (Volume 154, Number 9), with the Commentary/Perspectives entry "Searching for the Uncommon: The Future of Population Science in Cardiovascular Disease" by M.R. Carnethon (p. 787) circled in orange. Right panel, on a light gray background: bold red text reading "INSIDE THE JOURNAL:" above "MERCEDES CARNETHON, PHD" in gray, with "Deputy Editor, Population Health" below in italic gray. A circular headshot of Dr. Carnethon — smiling, dark hair, wearing a blue top — sits in the lower right, framed in red. AHA logo in the lower left of the cover panel.

1
6
18
1,178
It has been an immense privilege to lead this trial, and report on it at @escardio congress. All clinical trials are hard, investigator initiated trials even more so. Thank you to all investigators, trial staff, steering committee, DSMB, CEC and DDC members, and most of all patients and families who took part in the trial
Vineeta Ojha@vineetao17Aug 29
🫀 CMR-GUIDE @ #ESCCongress2026, published in JAMA. 353 pts, LVEF 36–50% + #whyCMR scar, randomized to ICD vs loop recorder. ▪️ Primary endpoint neutral: HR 0.76 (0.37–1.66) ▪️ SCD lower with ICD: 1.7% vs 5.8% ▪️ Prespecified subgroup: benefit in patients <70 @SCMRorg
3
7
353
Betty Raman retweeted
Circulation@CircAHAAug 26
Meet AHA Journals Editors at ESC! Join Editors from @CircAHA to learn about what topics are most of interest, how best to present your work, and other tips. #ESCCongress 📅 Sat, Aug 29 @ 6-8pm CEST 📍Hotel Bayerischer Hof, Konigssaal (King's Hall)
2
4
1
11
3,391
Inside the Journal: Practice changing. Sometimes surprising. When well-designed, always informative. Our commitment to clinical trials takes shape today with a Perspective by @texhern. He outlines what we're looking for: relevance to real clinical decisions, reach into the populations where disease actually occurs, rapid learning through adaptive design, and rigor that never bends. This @CircAHA is ready to lead the way in cardiovascular clinical trial research. Read the Perspective: ahajournals.org/doi/full/10.… @American_Heart | #Cardiology #Circulation #ClinicalTrials
Circulation journal cover for Volume 154, Number 7, August 18, 2026, with the Perspectives listing for 'Pursuing Clinical Trials "Adaptable" to the Moment' by AF Hernandez circled in yellow, beside a graphic reading 'Inside the Journal: Adrian F. Hernandez, MD, MHS, Deputy Editor, Clinical Trials,' with a circular red-framed headshot of Dr. Hernandez, a smiling man wearing a navy suit and gold tie.

ALT Circulation journal cover for Volume 154, Number 7, August 18, 2026, with the Perspectives listing for 'Pursuing Clinical Trials "Adaptable" to the Moment' by AF Hernandez circled in yellow, beside a graphic reading 'Inside the Journal: Adrian F. Hernandez, MD, MHS, Deputy Editor, Clinical Trials,' with a circular red-framed headshot of Dr. Hernandez, a smiling man wearing a navy suit and gold tie.

9
20
1,175
A New Era of @CircAHA: New chapter, new voices. Alongside @kejoynt and @HeartDocSadiya, I'm excited about where Circulation is headed — and why we want you to be part of it. Take a watch. We look forward to seeing many of you later this month at ESC Congress 2026 in Munich. @American_Heart | #Cardiology #Circulation #ESCCongress2026
2
3
25
1,453
Inside the Journal: Clinical research is the bedrock of progress in cardiovascular medicine. Hypothesis generating. Hypothesis testing. Moving basic science forward. Enabling clinical trial development. At @CircAHA, @JenHoCardiology and Dr. Ryan Tedford are the widely respected and deeply knowledgeable captains of this important mission. This week, they outline their vision of where clinical research is headed and establish our priorities on this critical topic at the journal. Their guiding standard: does a paper pass the "coffee table test" — will clinicians stop, read, discuss, and reconsider practice? Every submission gets weighed against three questions: Is it done well? Is it novel? Is it clinically actionable? The vision: clinical cardiology sits at the convergence of mechanisms of disease, therapeutic innovation, and systems and population impact — and the next era of discovery will come from connecting disciplines, not deeper silos. Full Perspective: ahajournals.org/doi/full/10.… @American_Heart | #Cardiology #Circulation #ClinicalCardiology
Circulation journal cover beside a graphic reading 'Inside the Journal: Clinical Cardiology at the Crossroads: Perspectives on the Next Era at Circulation, Jennifer E. Ho, MD & Ryan J. Tedford, MD,' paired with the article's own figure showing 'Curate, Distill, Contextualize' with four pillars — Rigor, Mechanistic Insight, Actionability, and Clinical Impact — the 'coffee table test,' and a diagram of Clinical Cardiology at the convergence of Global Health/Population Science, Basic/Translational Science, Hemodynamics/Physiology, Advanced Imaging, AI, Clinical Trials, Implementation Science, and Devices.

ALT Circulation journal cover beside a graphic reading 'Inside the Journal: Clinical Cardiology at the Crossroads: Perspectives on the Next Era at Circulation, Jennifer E. Ho, MD & Ryan J. Tedford, MD,' paired with the article's own figure showing 'Curate, Distill, Contextualize' with four pillars — Rigor, Mechanistic Insight, Actionability, and Clinical Impact — the 'coffee table test,' and a diagram of Clinical Cardiology at the convergence of Global Health/Population Science, Basic/Translational Science, Hemodynamics/Physiology, Advanced Imaging, AI, Clinical Trials, Implementation Science, and Devices.

1
12
31
2,389
Does extensive LGE on CMR in dilated cardiomyopathy = an ICD? Not necessarily. Our new @CircAHA Clinician Lighthouse discusses a practical approach to interpreting LGE and integrating it with LVEF, genotype, arrhythmias, and clinical context. #CMR bit.ly/4w1xcJn
1
1
5
485
more replies
3 practical lessons from our @CircAHA Clinician Lighthouse: 1️⃣ Recognise LGE pattern → Ischaemic or non-ischaemic? 2️⃣ Integrate risk → Consider LVEF, ventricular arrhythmias, genotype and family history. 3️⃣ shared decision with patient. LGE, in isolation may not = ICD.
1
2
73
@RDMOxford @UniofOxford @OxfordMedSci bit.ly/4w1xcJn

Late Gadolinium Enhancement in Nonischemic Dilated Cardiomyopathy | Circulation

ahajournals.org
1
46
Load more